Skip to content

Effect of a novel plant extract on the severity and duration of infectious diarrhoea in children and adults

Assessment of the therapeutic effect of LiveXtract, a novel plant extract, on the severity and duration of infectious diarrhoea in children and adults: a randomised double-blind placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11621877
Enrollment
736
Registered
2015-01-21
Start date
2012-05-10
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhoea Digestive System Diarrhoea

Interventions

1. LiveXtract solution mixed with ORS 2. Water mixed with ORS

Sponsors

LiveLeaf Inc
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Age 6 months old to 60 years old 2. Acute watery diarrhoea (for 48 hours or less)

Exclusion criteria

Exclusion criteria: 1. Fever 2. Bloody stool with or without abdominal pain 3. Clinical signs of coexisting severe acute systemic illness 4. Underlying severe chronic disease 5. Severe malnutrition 6. Signs of internal bleeding or black stools 7. Signs of drug abuse 8. Food allergy or other chronic gastrointestinal disease 9. Use of antibiotics or any anti-diarrhoeal medication during the previous 2 weeks 10. Any condition that the admitting physician believes will place the patient at risk if enrolled in the study 11. Participants whose stool cultures show Shigella spp 12. Unable or unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frame
Reduction in the severity and duration of diarrhoea, measured as the time the stool is ranked as a 4 or less on the Bristol Stool Scale

Secondary

MeasureTime frame
1. Volume of ORS consumed from the time of randomisation to resolution of diarrhoea 2. Number of events and duration of emesis These outcomes will be monitored every 6 hours for 4 days and ranked with a Visual Analogue Scale of 0 to 10.

Countries

Bangladesh

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026